Trigger FingerSplint TherapyParaffin BathPeloidotherapyEfficacy and SafetyRandomised Clinical Trial
Investigational drug(s) / intervention(s)
Finger orthosisParaffin bathPeloidotherapy
Finger orthosis: Joint-blocking finger orthosis plus home-based exercise therapy
Paraffin bath: Paraffin bath plus home-based exercise therapy
Peloidotherapy: Peloidotherapy plus home-based exercise therapy
Study summary
Patients aged 18-75 years who present with trigger finger to a tertiary rehabilitation hospital and agree to participate will be included in the study. Participants will be randomly allocated into three groups using block randomization. The first group will use a static finger splint that blocks the proximal interphalangeal joint for 6 weeks, along with a home exercise program. The second group will receive paraffin bath therapy, and the third group will receive peloidotherapy, both in combination with home exercises.
All patients will receive education about the disease and activity modification. The finger joint-restricting splint and exercises will be applied for 6 weeks. Evaluations will be conducted at baseline, at the end of the 3rd week, and at the end of the 6th week by a blinded assessor. No analgesic or anti-inflammatory medication will be permitted during the study, and patients will be instructed to avoid using analgesics within 24 hours prior to each assessment.
Eligibility
Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria:
* Being between 18 and 75 years of age and willing to participate in the study
* Having a diagnosis of idiopathic single trigger finger, Grade 2-3
Exclusion Criteria:
* Patients with triggering in more than one finger
* Patients with triggering at the A3 pulley or with Grade 1 or Grade 4 trigger finger
* Patients with thumb (pollex) trigger finger
* Patients who have undergone any injection or interventional procedure (release surgery) for trigger finger within the past 6 months
* Patients who have received physical therapy for the hand within the past 6 months
* Patients currently using corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs)
* Patients with inflammatory or autoimmune rheumatologic diseases such as rheumatoid arthritis, systemic lupus erythematosus, gout, or psoriatic arthritis
* Patients with other musculoskeletal disorders (e.g., carpal tunnel syndrome, de Quervain's tenosynovitis, symptomatic hand osteoarthritis, or Dupuytren's contracture) or neurological diseases (e.g., stroke-related hemiparesis, spinal cord injury, brachial plexus injury, multiple sclerosis, or Parkinsonism) affecting the same hand
* Patients with musculoskeletal disorders causing pain and/or limitation in the proximal upper extremity on the affected side (e.g., periarthritis, lateral epicondylitis, mononeuropathy, or radiculopathy)
* Patients with significant metabolic diseases (e.g., hypothyroidism, Cushing's syndrome, or uncontrolled diabetes)
* Patients with any condition that may interfere with treatment, such as open wounds, rashes, local infections, or active malignant disease of the hand
* Patients with a history of hand trauma (chronic or repetitive)
* Patients unwilling to complete the self-assessment questionnaires either independently or with assistance
* Pregnant women
Primary outcome measure(s)
VAS pain — Baseline, week 3 and week 6 VAS pain: 0 no pain; 10 unbearable/max. pain.
Green's classification (Grades 1-4) — Baseline, week 2 and week 6 Trigger finger classified according to Green's classification (Grades 1-4) Grade 1 - Pretriggering: Pain in the palm and tenderness over the A1 pulley, with a history of triggering not demonstrable on examination.
Grade 2 - Active Triggering: Triggering is clinically evident, but the patient can actively extend the finger.
Grade 3 - Passive Triggering:
3a: Locking is present and requires passive extension.
3b: Locking is present, and the patient cannot actively flex the finger.
Grade 4 - Contracture: The finger is completely locked with a fixed flexion contracture at the PIP joint.
Michigan Hand Outcomes Questionnaire (MHQ) — Baseline, week 2 and week 6 The Michigan Hand Outcomes Questionnaire (MHQ) is a comprehensive self-reported questionnaire developed to evaluate hand function, pain, and patient satisfaction. It is used to assess the functional status of individuals with upper extremity disorders and consists of six subscales: Overall Hand Function, Activities of Daily Living, Work Performance, Pain, Aesthetics, and Satisfaction. The Turkish version of the MHQ has undergone linguistic and cultural adaptation processes, and its validity and reliability have been established. Studies have demonstrated that the Turkish MHQ has high internal consistency and test-retest reliability, supporting its use in both clinical practice and research for assessing hand and wrist problems. The MHQ is scored on a scale ranging from 1 to 100. Except for the pain subscale, higher scores indicate better hand function and satisfaction, whereas higher pain scores represent greater pain intensity. The overall hand health status is determined by cal
Trial sites (1)
Facility
City
Region
Status
Konya Beyhekim Training and Research Hospital
Konya
Konya
Recruiting
More Konya Beyhekim Training and Research Hospital trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.